Overview
- The XXIX national meeting of Spain’s Urologic Oncology Working Group in Vigo logged 615 registrations, far above the usual 300–400, which organizers linked to the host city, fresher session formats, and industry backing.
- In prostate cancer, speakers highlighted sharper imaging that maps tumor spread more precisely and reported data that treatment combinations in advanced disease improve survival.
- For bladder cancer, the meeting’s coordinator said immunotherapy stands out as the most important recent advance and predicted it could reshape care.
- Discussion on kidney tumors focused on case-by-case choices, such as managing small lesions in older patients, with calls for multidisciplinary review and decisions that reflect each patient’s goals.
- At the opening, Galicia’s health chief noted 3,920 robot-assisted urology surgeries since 2021, a pilot prostate screening program starting in Ferrol, and the use of artificial intelligence to speed and refine diagnosis.